H Marijke van den Berg

10PUBLICATIONS
30CO-AUTHORS
HaematologyInfant and child healthAnimal protection (incl. pests and pathogens)Human biophysics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Mar 24, 2025
Blood Group O Does Not Increase the Risk of Inhibitors in Severe Haemophilia A: Data from the PedNet Study Group.

Marloes de Kovel, Aimée-Claire van Haaster, Manuel Carcao

|Dec 26, 2022
Primary prophylaxis in children with severe haemophilia A and B-Implementation over the last 20 years as illustrated in real-world data in the PedNet cohorts.

Rolf Ljung, Marloes de Kovel, H Marijke van den Berg

|Aug 04, 2020
WFH Guidelines for the Management of Hemophilia, 3rd edition.

Alok Srivastava, Elena Santagostino, Alison Dougall

|Jul 07, 2020
Inhibitor development in previously untreated patients with severe haemophilia: A comparison of included patients and outcomes between a clinical study and a registry-based study.

Carla J Jonker, Katrien Oude Rengerink, Arno W Hoes

|Jun 13, 2019
Timing of inhibitor development in more than 1000 previously untreated patients with severe hemophilia A.

H Marijke van den Berg, Kathelijn Fischer, Manuel Carcao

|May 23, 2018
International collaboration is needed to reduce the risk for inhibitors in PUPs with severe haemophilia A.

H M van den Berg

Pageof 2